We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$277B
AUM Growth
+$17B
Cap. Flow
+$10.3B
Cap. Flow %
3.74%
Top 10 Hldgs %
13%
Holding
7,048
New
169
Increased
3,077
Reduced
2,915
Closed
401

Sector Composition

Rank Sector Weight
1 Healthcare 8.93%
2 Technology 8.69%
3 Financials 8.37%
4 Communication Services 6.94%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUIK icon
6176
QuickLogic
QUIK
$232M
$2K ﹤0.01%
147
-137
-48% -$1.96K
SNOA icon
6177
Sonoma Pharmaceuticals
SNOA
$5.26M
$2K ﹤0.01%
2
-1
-33% -$861
MMAT
6178
DELISTED
Meta Materials Inc. Common Stock
MMAT
$2K ﹤0.01%
+20
New +$2.79K
GENE
6179
DELISTED
Genetic Technologies Ltd.
GENE
$2K ﹤0.01%
50
-274
-85% -$12.6K
EIGR
6180
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2K ﹤0.01%
3
-30
-91% -$18.2K
ONCT
6181
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2K ﹤0.01%
3
-1
-25% -$935
UFAB
6182
DELISTED
Unique Fabricating, Inc.
UFAB
$2K ﹤0.01%
+123
New +$1.62K
ACER
6183
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
47
-1
-2% -$30
CYTO
6184
DELISTED
Altamira Therapeutics Ltd
CYTO
0
UNVR
6185
DELISTED
Univar Solutions Inc.
UNVR
$2K ﹤0.01%
+125
New +$2.27K
ABTX
6186
DELISTED
Allegiance Bancshares
ABTX
$2K ﹤0.01%
100
ICBK
6187
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$2K ﹤0.01%
100
-9
-8% -$189
STML
6188
DELISTED
Stemline Therapeutics, Inc.
STML
$2K ﹤0.01%
222
-302
-58% -$1.91K
BDCL
6189
DELISTED
2Leveraged Long ETRACS Linked to the Wells Fargo Business Dev
BDCL
$2K ﹤0.01%
114
MCRN
6190
DELISTED
Milacron Holdings Corp.
MCRN
$2K ﹤0.01%
+105
New +$1.7K
SEII
6191
DELISTED
Sharing Economy International Inc. Common Stock (NV)
SEII
$2K ﹤0.01%
500
-2
-0.4% -$9
ONSIW
6192
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$2K ﹤0.01%
+5,830
New +$2.23K
PRSS
6193
DELISTED
CafePress Inc.
PRSS
$2K ﹤0.01%
658
-1,066
-62% -$3.62K
COF.WS
6194
DELISTED
Capital One Financial Corp
COF.WS
$2K ﹤0.01%
100
BAC.WS.B
6195
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$2K ﹤0.01%
26,900
+11,000
+69% +$1.69K
CWAY
6196
DELISTED
Coastway Bancorp, Inc.
CWAY
$2K ﹤0.01%
121
-8
-6% -$100
ONSIZ
6197
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$2K ﹤0.01%
+5,830
New +$3.07K
NRCIB
6198
DELISTED
National Research Corp Class B
NRCIB
$2K ﹤0.01%
50
-5
-9% -$184
EVAR
6199
DELISTED
Lombard Medical, Inc.
EVAR
$2K ﹤0.01%
1,863
-28
-1% -$39
GGOV
6200
DELISTED
ProShares German Sovereign/Sub-Sovereign ETF
GGOV
$2K ﹤0.01%
+50
New +$1.88K

Similar funds

Morgan Stanley's Q2 2016 Portfolio in Review

As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.

By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.

  • Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
  • Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
  • Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
  • Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
  • Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.